<< back
COVID-19 - Biopharma’s agility put at test
Research
Publication Date: 25 Mar 2020 - By Scitaris G. By Scitaris G.Thematic Multi Asset Global Biotechnology Pharmaceuticals
Share
Scitaris, a leading biotech and pharma consultancy, is providing a perspective on the biological characteristics of the virus, including:
- implications on its transmission and potential ends to the pandemic
- focusing the race of the biopharma industry to finding a cure
- considerations for investors in the space
Most read
At ReachX, we are accelerating the world's most ambitious projects and deals
Fifth Floor, 11 Leadenhall Street, EC3V 1LP London, UK (registered)
120 Regent Street, W1B 5FE London, UK (business)
120 Regent Street, W1B 5FE London, UK (business)